Neurochemistry of Metabolic Diseases: Lysosomal Storage Diseases, Phenylketonuria and Canavan Disease

$175.00

Sankar Surendran (Editor)
College Station, TX, US

Series: Metabolic Diseases – Laboratory and Clinical Research

Metabolic disorder is caused by a gene defect, environmental factors or an unknown etiology. Altered metabolism caused by these factors affects normal function of various organs including the brain and may lead to abnormal phenotype. Understanding agents of causing these abnormalities is useful to interpret possible targets in these diseases. This book reveals what factors contribute in lysosomal storage diseases, Phenylketonuria and Canavan disease, as they are major emerging diseases in multiethnic populations. (Imprint: Nova Biomedical Press)

Clear

Details

Preface pp. i -xiv

Chapter 1. Sialidosis: Pathophysiology and Therapeutic Approaches
(Eugen-Matthias Strehle) pp.1-14

Chapter 2. Gaucher disease and therapeutic approaches
(Deborah Elstein, Ehud Lebel, Gheona Altarescu, Irith Hadas-Halpern and Ari Zimran)pp.15-36

Chapter 3. Parkinson’s disease: molecular changes and therapeutic approaches
(Erich Richter, Marina Abramova and Sankar Surendran)pp.37-56

Chapter 4. Ataxia-telangiectasia: Clinical symptoms and therapeutic approaches
(Aggeliki Kolialexi and Ariadni Mavrou)pp.57-70

Chapter 5. Rett syndrome and therapeutic approaches
(Karine Pelc, Guy Cheron and Bernard Dan)pp.71-82

Chapter 6. Krabbe Disease and therapeutic approaches
(Patricia K. Duffner)pp.83-108

Chapter 7. Gangliosidoses: molecular pathology and therapeutic approaches
(Yoshiyuki Suzuki)pp.109-128

Chapter 8. Enzyme replacement therapy for lysosomal storage diseases
(Shunji Tomatsu,, Adriana M. Montaño, Angela Catalina Sosa Molano,et al.) pp.129-158

Chapter 9. Cell-based Gene Therapy for Lysosomal Storage Diseases
(Seung U. Kim)pp.159-168

Chapter 10. Biomarkers for lysosomal storage disorders
(Johannes M. F. G. Aerts, Maria Joao Ferraz, Rolf G. Boot, et al.)pp.169-202

Chapter 11. PKU in Turkey: screening, diagnosis and management
(Hülya Gökmen-Özel and Turgay Coþkun)pp.203-218

Chapter 12. Phenylketonuria and therapeutic approaches
(Erin L. MacLeod and Denise M. Ney)pp.219-240

Chapter 13. Canavan disease: molecular pathology, phenotype and therapeutic approaches
(Sankar Surendran, Namik Kaya and Pinar Ozand)pp.241-264

Contributors pp.265-268

Index pp.269-287

Additional information

Binding

,